⟵ Back to Search Results
BGB-A317-A445-101

Active, not recruiting

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Beigene Study ID info

BGB-A317-A445-101

ClinicalTrials.gov ID info

NCT04215978

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents